Sign In
Buy BSX
$48.85
+1.16 (+2.43%)
At Close: Jun 04, 2026
HAE vs. BSX: Which Stock Is the Better Value Option?
12:42pm, Wednesday, 30'th Oct 2024
Investors interested in Medical - Products stocks are likely familiar with Haemonetics (HAE) and Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportu
ACURATE neo2™ Aortic Valve System Data Presented at Late-Breaking Clinical Trial Session at TCT 2024
11:41am, Wednesday, 30'th Oct 2024
MARLBOROUGH, Mass. and WASHINGTON , Oct. 30, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the results of the primary endpoint of the ACURATE IDE clinical trial, which
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Tuesday, 29'th Oct 2024
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
10:41am, Friday, 25'th Oct 2024
Here is how Boston Scientific (BSX) and Addex Therapeutics Ltd. Sponsored ADR (ADXN) have performed compared to their sector so far this year.
Boston Scientific Profit Falls Even as Demand for Its Heart Products Surges
02:35pm, Wednesday, 23'rd Oct 2024
Boston Scientific (BSX) shares fell Wednesday when the medical equipment manufacturer's third-quarter profit fell and its GAAP earnings per share (EPS) came in short of its guidance.
BSX Q3 Earnings Top, Stock Down in Premarket as Operating Margin Falls
02:00pm, Wednesday, 23'rd Oct 2024
Boston Scientific registers year-over-year improvement in sales, indicating solid market share gains in legacy businesses despite macroeconomic odds.
Boston Scientific Corporation (BSX) Q3 2024 Earnings Call Transcript
11:50am, Wednesday, 23'rd Oct 2024
Boston Scientific Corporation (NYSE:BSX ) Q3 2024 Earnings Conference Call October 23, 2024 8:00 AM ET Company Participants Jonathan Monson - Senior Vice President, Investor Relations Michael Mahoney
Compared to Estimates, Boston Scientific (BSX) Q3 Earnings: A Look at Key Metrics
11:01am, Wednesday, 23'rd Oct 2024
The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall St
Boston Scientific (BSX) Surpasses Q3 Earnings and Revenue Estimates
08:41am, Wednesday, 23'rd Oct 2024
Boston Scientific (BSX) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.50 per share a year ago.
Boston Scientific's stock climbs on Q3 sales and earnings beat
07:39am, Wednesday, 23'rd Oct 2024
Medical-products company Boston Scientific reported third-quarter results before market open.
Boston Scientific lifts annual profit forecast on strong demand for heart devices
07:06am, Wednesday, 23'rd Oct 2024
Boston Scientific raised its annual profit forecast and exceeded Wall Street's estimates for third-quarter profit on Wednesday, driven by robust demand for its heart devices, sending its shares higher
Boston Scientific Earnings, Sales Top Q3 Views; Stock Eyes High
06:54am, Wednesday, 23'rd Oct 2024
Boston Scientific earnings and sales beat Q3 views early Wednesday. The medtech giant's shares, right at record highs, rose before the open,
Boston Scientific Announces Results for Third Quarter 2024
06:30am, Wednesday, 23'rd Oct 2024
MARLBOROUGH, Mass. , Oct. 23, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.209 billion during the third quarter of 2024, growing 19.4 percent on a reported
Will These 3 MedTech Stocks Surpass Q3 Earnings Forecasts?
01:16pm, Tuesday, 22'nd Oct 2024
Here is a sneak peek into how three MedTech stocks, BSX, TMO and ALGN, are expected to fare in their third-quarter results, slated to be released tomorrow.
Boston Scientific Q3 Earnings Preview
09:55am, Tuesday, 22'nd Oct 2024
Boston Scientific (NYSE: BSX) is scheduled to report its Q3 2024 results on Wednesday, October 23. We expect the company to report revenues and earnings slightly below the consensus estimates.
